These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Specific features of diagnosis and treatment of patients with pulmonary sarcoidosis and tuberculosis]. Kostina ZI; Brazhenko NA; Gerasimova EV; Kol'nikova OV Probl Tuberk; 1998; (2):10-3. PubMed ID: 9613175 [TBL] [Abstract][Full Text] [Related]
47. Cervico-mediastinal lymphadenopathy as a paradoxical response to chemotherapy in pulmonary tuberculosis. A case report. Janmeja AK; Das SK Respiration; 2003; 70(2):219-20. PubMed ID: 12740523 [TBL] [Abstract][Full Text] [Related]
48. [Effect of bronchial pathology on the results of treatment of pulmonary tuberculosis]. Shesterina MV; Kim ACh; Agafonnikova KI; Rzhavskov IuV; Barchakhova ZI Probl Tuberk; 1974; (8):21-3. PubMed ID: 4409353 [No Abstract] [Full Text] [Related]
49. [Efficiency treatment of new cases of destructive pulmonary tuberculosis in the presence of concurrent iron deficiency anemia]. Voloshina VV; Fomicheva NI Probl Tuberk; 2002; (2):10-2. PubMed ID: 11899794 [TBL] [Abstract][Full Text] [Related]
50. [Vitamin B1 metabolism in patients with pulmonary tuberculosis at the time of combined antibacterial therapy]. Kiselova ES Sov Med; 1973 Jul; 36(7):138-9. PubMed ID: 4776691 [No Abstract] [Full Text] [Related]
51. [Comparison of several methods of treating pulmonary tuberculosis]. Garbuz VM Klin Med (Mosk); 1972 May; 50(5):112-7. PubMed ID: 4340193 [No Abstract] [Full Text] [Related]
52. [On the dynamics of 17-ketosteroid content in the urine of tuberculous patients treated with antibacterial drugs and prednisolone]. Tsigel'nik AIa; Volkova KI Probl Tuberk; 1965; 43(11):65-71. PubMed ID: 5875737 [No Abstract] [Full Text] [Related]
53. [Nicotinic acid metabolism in patients with pulmonary tuberculosis before therapy and during antibacterial therapy]. Belozorov PT; Vil'nianskiĭ LI; Miroshnikova VI Probl Tuberk; 1967; 45(4):55-9. PubMed ID: 5606806 [No Abstract] [Full Text] [Related]
54. [Therapeutic failure despite sensitive germs]. Zierler W Wien Med Wochenschr; 1968 Oct; 118(43):921-3. PubMed ID: 4973922 [No Abstract] [Full Text] [Related]
55. [Effect of antioxidant therapy on lipid peroxidation in patients with acute and protracted pneumonia]. Borovkova MS; Mashchakevich II Klin Med (Mosk); 1988 Dec; 66(12):62-4. PubMed ID: 3230853 [No Abstract] [Full Text] [Related]
56. [Use of rheopulmonography in assessing the effectiveness of pathogenetic agents in the combined treatment of pulmonary tuberculosis patients]. Skiba VP Probl Tuberk; 1986; (1):30-2. PubMed ID: 3960837 [No Abstract] [Full Text] [Related]
57. [The state of metabolic processes in patients with pulmonary tuberculosis under hormonal and antibacterial therapy]. Litvin LM; Chertkova MA; Kharakter ZhZ Probl Tuberk; 1968; 46(5):34-41. PubMed ID: 5708497 [No Abstract] [Full Text] [Related]
58. [Clinico-biomedical characteristics in manifestations of drug intolerance in patients with pulmonary tuberculosis]. Sergeev IS; Ignatova AV Sov Med; 1973 Jul; 36(7):35-9. PubMed ID: 4776705 [No Abstract] [Full Text] [Related]
59. [Antimycobacterial therapy before results of the antibiogram: importance of multiple combinations to improve the prognosis of cavitary pulmonary tuberculosis. Clinico-statistical study]. Lukinovich N; Robotti E; Bettini L G Ital Mal Torace; 1967; 21(6):283-94. PubMed ID: 5616373 [No Abstract] [Full Text] [Related]
60. [Current socioepidemiologic and clinico-pathogenetic aspects of pulmonary tuberculosis in the Republic of Moldova]. Sain DO; Iavorskii KM; Emel'ianov OS; Bolotnikova VA; Brumar' AG Probl Tuberk; 1997; (1):17-9. PubMed ID: 9162912 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]